Pneumococcal Vaccine comment watch save

  • TRADE NAMES: PCV (Lederle); PncOMP (Merck); Pneumovax II (Sanofi-Aventis); Pnu-Immune (Lederle); PPV (Lederle); Prevnar (Wyeth)
  • INDICATIONS: Prevention of bacteremia, meningitis, pneumonia, respiratory tract infections, otitis media, sinusitis
  • CLASS: Vaccine
  • HALF-LIFE: N/A
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    None known

Please login to view the rest of this drug profile.

    DRUG REVIEW ARTICLE

    Click on the DRUG REVIEW ARTICLE tab (above) to see a review of pneumococcal vaccine in the Taylor & Francis journal Expert Opinion on Drug Safety.

     

    (Note that non-subscribers to the journal will only be able to see an abstract of the article.)

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top